[go: up one dir, main page]

RU2010112734A - METHOD FOR ELIMINATION OF GARDNERELLA VAGINALIS AND ATOPOBIUM VAGINAE BACTERIA IN BACTERIAL VAGINOSIS - Google Patents

METHOD FOR ELIMINATION OF GARDNERELLA VAGINALIS AND ATOPOBIUM VAGINAE BACTERIA IN BACTERIAL VAGINOSIS Download PDF

Info

Publication number
RU2010112734A
RU2010112734A RU2010112734/15A RU2010112734A RU2010112734A RU 2010112734 A RU2010112734 A RU 2010112734A RU 2010112734/15 A RU2010112734/15 A RU 2010112734/15A RU 2010112734 A RU2010112734 A RU 2010112734A RU 2010112734 A RU2010112734 A RU 2010112734A
Authority
RU
Russia
Prior art keywords
elimination
bacteria
gardnerella vaginalis
atopobium vaginae
bacterial vaginosis
Prior art date
Application number
RU2010112734/15A
Other languages
Russian (ru)
Other versions
RU2445964C2 (en
Inventor
Юрий Николаевич Перламутров (RU)
Юрий Николаевич Перламутров
Михаил Александрович Гомберг (RU)
Михаил Александрович Гомберг
Надежда Ивановна Чернова (RU)
Надежда Ивановна Чернова
Ольга Игоревна Бочкова (RU)
Ольга Игоревна Бочкова
Марино Лоренцо Касторина (AT)
Марино Лоренцо Касторина
Виктор Иванович Удовиченко (RU)
Виктор Иванович Удовиченко
Original Assignee
Общество с ограниченной ответственностью "Салмос" (RU)
Общество с ограниченной ответственностью "Салмос"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Салмос" (RU), Общество с ограниченной ответственностью "Салмос" filed Critical Общество с ограниченной ответственностью "Салмос" (RU)
Priority to RU2010112734/15A priority Critical patent/RU2445964C2/en
Priority to PCT/RU2010/000739 priority patent/WO2011122978A1/en
Publication of RU2010112734A publication Critical patent/RU2010112734A/en
Application granted granted Critical
Publication of RU2445964C2 publication Critical patent/RU2445964C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Способ элиминации бактерий Gardnerella vaginalis и Atopobium vaginae, характеризующийся тем, что используют препарат «Макмирор Комплекс», который вводят по одной свече во влагалище один раз в день в течение семи-восьми дней. The method of elimination of bacteria Gardnerella vaginalis and Atopobium vaginae, characterized in that they use the drug "Macmirror Complex", which is administered one candle into the vagina once a day for seven to eight days.

Claims (1)

Способ элиминации бактерий Gardnerella vaginalis и Atopobium vaginae, характеризующийся тем, что используют препарат «Макмирор Комплекс», который вводят по одной свече во влагалище один раз в день в течение семи-восьми дней. The method of elimination of bacteria Gardnerella vaginalis and Atopobium vaginae, characterized in that they use the drug "Macmirror Complex", which is administered one candle into the vagina once a day for seven to eight days.
RU2010112734/15A 2010-04-02 2010-04-02 Method for eliminating atopobium vaginae bacteria in treating bacterial vaginosis RU2445964C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2010112734/15A RU2445964C2 (en) 2010-04-02 2010-04-02 Method for eliminating atopobium vaginae bacteria in treating bacterial vaginosis
PCT/RU2010/000739 WO2011122978A1 (en) 2010-04-02 2010-12-08 Method for eliminating gardnerella vaginalis and atopobium vaginae bacteria in bacterial vaginosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010112734/15A RU2445964C2 (en) 2010-04-02 2010-04-02 Method for eliminating atopobium vaginae bacteria in treating bacterial vaginosis

Publications (2)

Publication Number Publication Date
RU2010112734A true RU2010112734A (en) 2011-10-10
RU2445964C2 RU2445964C2 (en) 2012-03-27

Family

ID=44712445

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010112734/15A RU2445964C2 (en) 2010-04-02 2010-04-02 Method for eliminating atopobium vaginae bacteria in treating bacterial vaginosis

Country Status (2)

Country Link
RU (1) RU2445964C2 (en)
WO (1) WO2011122978A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107137415A (en) * 2017-05-19 2017-09-08 武汉人福药业有限责任公司 A kind of three-dimensional nysfungin suppository and preparation method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2585423C1 (en) * 2015-03-10 2016-05-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральский государственный медицинский университет Министерства здравоохранения Российской Федерации" (ГБОУ ВПО УГМУ Минздрава России) Method of treating hpv associated cervical neoplasias ii-iii degree
EP3388063A1 (en) * 2017-04-14 2018-10-17 Adamed sp. z o.o. Treatment of a bacterial vaginal infection
CN108853003A (en) * 2018-06-19 2018-11-23 南京南大药业有限责任公司 A kind of Nifuratel-Nysfungin soft-capsule type suppository and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107137415A (en) * 2017-05-19 2017-09-08 武汉人福药业有限责任公司 A kind of three-dimensional nysfungin suppository and preparation method thereof
CN107137415B (en) * 2017-05-19 2019-09-03 武汉人福药业有限责任公司 A kind of three-dimensional nysfungin suppository and preparation method thereof

Also Published As

Publication number Publication date
WO2011122978A1 (en) 2011-10-06
RU2445964C2 (en) 2012-03-27

Similar Documents

Publication Publication Date Title
EA201001577A1 (en) DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PRODUCTION
MD4577B1 (en) Chewable compositions for veterinary use containing an isoxazoline active agent and their use for the treatment or prevention of parasitic infestation or infection
EA201270566A1 (en) ANTIMICROBIAL COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
MX2022013590A (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF ATTENTION DEFICIT DISORDER.
EA201270567A1 (en) ANTIMICROBIAL COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
EA201291034A1 (en) APTAMERS TO β-NGF AND THEIR APPLICATION IN THE TREATMENT OF B-NGF-MEDIATED DISEASES AND DISORDERS
UA112288C2 (en) Antibody forvulation and therapeutic regimens
CO6680667A2 (en) Ester derivatives of cyclic boronic acid and its therapeutic uses
BR112012023021A2 (en) indazole compounds and their uses
CR20110318A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS TO BE USED IN THE TREATMENT OF METABOLIC DISORDERS
MX363000B (en) Methods and compositions for treating inflammation.
EA201490264A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMIN, METHODS OF THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
EA201390626A1 (en) DERIVATIVES OF HYDROXAMIC ACID AND APPLICATION OF INDICATED DERIVATIVES IN THE TREATMENT OF BACTERIAL INFECTIONS
EA201201658A1 (en) DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
EA201171270A1 (en) APPLICATION OF NIFURATEL IN THE TREATMENT OF INFECTIONS CAUSED BY ATOPOBIUM
EA201690005A1 (en) COMPOSITION WITH MODIFIED EXTRUSION KINETICS
EA201490045A1 (en) DEUTERED 1-PIPERAZINO-3-PHENYLINDANES USED TO TREAT SCHIZOPHRENIA
RU2010112734A (en) METHOD FOR ELIMINATION OF GARDNERELLA VAGINALIS AND ATOPOBIUM VAGINAE BACTERIA IN BACTERIAL VAGINOSIS
BR112012024999A2 (en) combination and use
EA201071209A1 (en) APPLICATION OF DRUNEDARON OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR OBTAINING A MEDICINE TO REGULATE KALIUM IN THE BLOOD
CL2010001577A1 (en) Use of nifurtimox to prepare a useful medicine in the treatment of diseases caused by giardias.
PH12019502332A1 (en) Treatment of a bacterial vaginal infection
CL2007003660A1 (en) USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.
RU2012129115A (en) METHOD FOR TREATING ACUTE POST-PERMANENT ENDOMETRITIS IN COWS

Legal Events

Date Code Title Description
PC41 Official registration of the transfer of exclusive right

Effective date: 20130705

MM4A The patent is invalid due to non-payment of fees

Effective date: 20180403